Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Окулист (Oculist) is a multi-ingredient dietary supplement developed by the Russian company Diod (Factory of Ecological Technology and Eco-Nutrition). It is formulated to support ophthalmologic health and maintain visual acuity, particularly under conditions of high visual stress or age-related decline. The supplement contains a combination of bilberry extract (rich in anthocyanins), beta-carotene, vitamin E, zinc, and selenium. These ingredients function collectively as antioxidants and essential nutrients to protect the retina from oxidative damage, support the regeneration of the visual pigment rhodopsin, and improve microcirculation within ocular tissues. As a dietary supplement (БАД), it is intended for nutritional support and is not classified as a pharmaceutical drug for the treatment of specific diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Окулист.